Cancer and ageing: rival demons?
The DOI matches its Crossref record; 161 of the 161 references it cites were found in a registry or an index.
Abstract
Organisms with renewable tissues use a network of genetic pathways and cellular responses to prevent cancer. The main mammalian tumour-suppressor pathways evolved from ancient mechanisms that, in simple post-mitotic organisms, act predominantly to regulate embryogenesis or to protect the germline. The shift from developmental and/or germline maintenance in simple organisms to somatic maintenance in complex organisms might have evolved at a cost. Recent evidence indicates that some mammalian tumour-suppressor mechanisms contribute to ageing. How might this have happened, and what are its implications for our ability to control cancer and ageing?
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several lines of evidence indicate that cellular senescence is a potent tumor-suppressive mechanism [ 4 , 9 , 10 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [10]
In the citing paper
“Despite support for the idea that senescence is a beneficial anticancer mechanism, indirect evidence suggests that senescent cells can also be deleterious and might contribute to age-related pathologies [ 10 , 23 – 25 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [10]
In the citing paper
“It is a cellular program which acts as a double-edged sword, with both beneficial and detrimental effects on the health of the organism, and considered to be an example of evolutionary antagonistic pleiotropy.”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Campisi, 2003
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Apoptosis in the Pathogenesis and Treatment of Disease
Thompson, C. B. (1995) · Science · doi:10.1126/science.7878464 · Cited by 6,524 · cited 1×
“Apoptosis and ageing How might apoptosis contribute to ageing? In the somatic tissues of adult complex organisms, apoptosis is important for maintaining tissue homeostasis; defective apoptosis (either too little or too much) is associated with a number of disease”
BackgroundCDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Pleiotropy, natural selection, and the evolution of senescence.
Williams, G. C. (1957) · Evolution · doi:10.1111/j.1558-5646.1957.tb02911.x · Cited by 4,279
The regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317
The microenvironment of the tumour–host interface
Liotta, L. A., & Kohn, E. C. (2001) · Nature · doi:10.1038/35077241 · Cited by 2,310
Research works printed but not linked: 2
- Prives, C. & Hall, P. A. The p53 pathway. J. Pathol. 187, 112–126 (1999). · doi:10.1002/(sici)1096-9896(199901)187:1<112::aid-path250>3.0.co;2-3
- Davenport, J. Tumor-free but not in the clear. Science, SAGE–KE, 2002.
Cited by
Items 301–400 of 511
Kirchner, V. A., Badshah, J. S., Hong, S. K., Martinez, O. M., Pruett, T. L., & Niedernhofer, L. J. (2023) · Transplantation · doi:10.1097/tp.0000000000004838 · Cited by 16
den Reijer, P. M., Maier, A. B., Westendorp, R. G. J., & van Heemst, D. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.12.006 · Cited by 17
“It has been argued that cellular senescence is a double-edged sword in that it evolved to suppress cancer early in life, but may actually contribute to tumor formation later in life as senescent cells accumulate to sufficiently large numbers (Campisi, 2003, 2005).”
Cancer as a Programmed Death of an Organism
Lichtenstein, A. V. (2005) · Biochemistry (Moscow) · doi:10.1007/s10541-005-0224-y · Cited by 16
Molecular connections of obesity and aging: a focus on adipose protein 53 and retinoblastoma protein
Chu, D., & Tao, Y. (2017) · Biogerontology · doi:10.1007/s10522-017-9698-4 · Cited by 14
“There are two cellular pathways of aging which have the involvement of p53 tumor suppressor protein (p53) and the retinoblastoma protein (Rb) (Campisi 2003; Campisi and d'Adda di Fagagna 2007; Polager and Ginsberg 2009) (Fig 1).”
BackgroundInfluentialFunctional significance of MHC variation in mate choice, reproductive outcome, and disease risk
Loisel, D. A., Alberts, S. C., & Ober, C. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0008 · Cited by 15
Magnesium in cancer: more questions than answers
Leidi, M., Wolf, F. I., & Maier, J. A. M. (2011) · University of Adelaide Press eBooks · doi:10.1017/upo9780987073051.017 · Cited by 14
Christensen, K., Pedersen, J. K., Hjelmborg, J., Vaupel, J. W., Stevnsner, T., Holm, N. V., & Skytthe, A. (2012) · The Journals of Gerontology Series A · doi:10.1093/gerona/gls087 · Cited by 13
The Search for Biomarkers of Aging: Next Stop INK4a/ARF Locus
Dimri, G. P. (2004) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2004.44.pe40 · Cited by 15
Biological Interactions of Aging and Carcinogenesis
Anisimov, V. N. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-387-23962-6_2 · Cited by 13
Analyses of cancer incidence and other morbidities in gamma irradiated B6CF1 mice
Zander, A. D., Paunesku, T., & Woloschak, G. E. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231510 · Cited by 15
Ageing within the hematopoietic stem cell compartment
Pearce, D., & Bonnet, D. A. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.04.005 · Cited by 13
Genomic Progression in Mouse Models for Liver TumorsPreprint
Tward, A. D., Jones, K. D., Yant, S. R., Kay, M. A., WANG, R., & Bishop, J. M. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.058 · Cited by 13
Advances in cancer genomics and precision oncology
Heo, Y., Kim, W., Cho, Y., Jung, J., Kim, N., & Choi, I. (2025) · Genes & Genomics · doi:10.1007/s13258-024-01614-7 · Cited by 13
Role of mismatch repair in aging
Wen, J., Wang, Y., Yuan, M., Huang, Z., Zou, Q., Pu, Y., Zhao, B., & Cai, Z. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.64953 · Cited by 16
“Cell senescence has both advantages and disadvantages to the health of organisms and is considered to be an example of evolutionary antagonism [140-144].”
BackgroundChronic Mechanistic Target of Rapamycin Inhibition: Preventing Cancer to Delay Aging, or Vice Versa?
Sharp, Z. D., Curiel, T. J., & Livi, C. B. (2013) · Interdisciplinary topics in gerontology and geriatrics · doi:10.1159/000343625 · Cited by 11
de Abechuco, E. L., Bilbao, E., Soto, M., & Díez, G. (2014) · Gene · doi:10.1016/j.gene.2014.03.006 · Cited by 12
Analyses of cancer incidence and other morbidities in neutron irradiated B6CF1 mice
Zander, A. D., Paunesku, T., & Woloschak, G. E. (2021) · PLoS ONE · doi:10.1371/journal.pone.0231511 · Cited by 12
Chen, T., Wang, F., Wei, S., Nie, Y., Zheng, X., Deng, Y., Zhu, X., Deng, Y., Zhong, N., & Zhou, C. (2021) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0389 · Cited by 12
Имянитов, Е. Н. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.03.005 · Cited by 12
Human genetic variation of medical significance
Kídd, K. K., & Kidd, J. R. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0005 · Cited by 11
Pedersen, J. K., Skytthe, A., McGue, M. K., Honig, L. S., Franceschi, C., Kirkwood, T. B. L., Passarino, G., Slagboom, P. E., Vaupel, J. W., & Christensen, K. (2015) · Annals of Epidemiology · doi:10.1016/j.annepidem.2015.03.004 · Cited by 11
Xie, L., Gong, Y., Lian, S.-G., Yang, J., Yang, Y. P., Gao, S., Xu, L., & Zhang, Y. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.08.004 · Cited by 11
p53 – ein natürlicher Krebskiller: Einsichten in die Struktur und Therapiekonzepte
Römer, L., Klein, C., Dehner, A., Kessler, H., & Büchner, J. (2006) · Angewandte Chemie · doi:10.1002/ange.200600611 · Cited by 16
Lichtenstein, A. V. (2008) · Medical Hypotheses · doi:10.1016/j.mehy.2008.07.041 · Cited by 16
Kalampouka, I., Mould, R. R., Botchway, S. W., Mackenzie, A. M., Nunn, A. V. W., Thomas, E. L., & Bell, J. D. (2024) · Journal of Biophotonics · doi:10.1002/jbio.202400046 · Cited by 10
Fluen, T., Hardcastle, M., Smith, H. L., & Gear, R. N. A. (2019) · Veterinary Record Open · doi:10.1136/vetreco-2019-000367 · Cited by 10
Greenwell, J. C., Torres-González, E., Ritzenthaler, J. D., & Roman, J. (2020) · Cancer Biology & Therapy · doi:10.1080/15384047.2020.1831372 · Cited by 11
Carcinogenesis: Evolution of concepts
Lichtenstein, A. V. (2009) · Biochemistry (Moscow) · doi:10.1134/s0006297909040014 · Cited by 11
Introducing Evolutionary Thinking For Medicine
Stearns, S. C., Nesse, R. M., & Haig, D. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0001 · Cited by 18
The Dual Role of Senescence in Tumorigenesis
Chuaire, L., Sánchez, M. C., & Ramírez-Clavijo, S. R. (2010) · International Journal of Morphology · doi:10.4067/s0717-95022010000100006 · Cited by 13
“On the other hand, the presence of cells with senescence marker expression in tissues with hyperplastic pathological or premalignant alterations might indicate that senescence is a step in the process of tumor transformation or, that cancer development is age-dependant (Campisi, 2003a,b).”
BackgroundTP53 codon 72 polymorphism as a risk factor for cardiovascular disease in a Brazilian population
Smith, M. D. A. C., Silva, M. D. A., Cendoroglo, M. S., Ramos, L. R., Araújo, L. M. Q., de Lábio, R. W., Burbano, R. M. R., Chen, E. S., & Payão, S. L. M. (2007) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2006005000174 · Cited by 12
“A remarkable activity of p53 has been described in mutant mice which display early aging-associated phenotypes (8,9).”
BackgroundSharpless, N. E. (2003) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2003.33.pe24 · Cited by 14
Comprehensive Pan-Cancer Analysis of Senescence With Cancer Prognosis and Immunotherapy
Zhao, Q., Hu, W., Xu, J., Zeng, S., Xi, X., Chen, J., Wu, X., Hu, S., & Zhong, T. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.919274 · Cited by 12
“Previous studies reported that senescence plays multifaceted roles (suppressive or progressive effects) in tumorigenesis, depending on the context (Campisi, 2003; Collado et al., 2007).”
BackgroundKirsch‐Volders, M., & Fenech, M. F. (2023) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2023.108474 · Cited by 10
The cause of cancer mutations: Improvable bad life or inevitable stochastic replication errors?
Алексеенко, И. В., Kuzmich, A. I., Pleshkan, V. V., Tyulkina, D. V., Zinovyeva, M. V., Костина, М. Б., & Sverdlov, E. D. (2016) · Molecular Biology · doi:10.1134/s0026893316060030 · Cited by 9
Mehta, I. S., Riyahi, K., Pereira, R. T., Meaburn, K. J., Figgitt, M., Kill, I. R., Eskiw, C. H., & Bridger, J. M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.640200 · Cited by 12
Studying health histories of cancer: A new model connecting cancer incidence and survival
Yashin, A. I., Akushevich, I. V., Arbeev, K. G., Akushevich, L., Kulminski, A. M., & Ukraintseva, S. V. (2009) · Mathematical Biosciences · doi:10.1016/j.mbs.2008.12.007 · Cited by 10
Recent advances in melanoma research
Jon, A. R. (2006) · Frontiers in bioscience · doi:10.2741/2028 · Cited by 9
Aging alters acute apoptotic response to azoxymethane in the colon of rats
Kwon, Y., & Magnuson, B. A. (2007) · Experimental Gerontology · doi:10.1016/j.exger.2007.09.011 · Cited by 9
Warny, M., Helby, J., Sengeløv, H., Nordestgaard, B. G., Birgens, H., & Bojesen, S. E. (2018) · European Journal Of Haematology · doi:10.1111/ejh.13196 · Cited by 11
Replicative Senescence and Cancer
Hornsby, P. J. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-387-23962-6_3 · Cited by 11
Open-Ended Question: Is Immortality Exclusively Inherent to the Germline? – A Mini-Review
Lepperdinger, G. (2008) · Gerontology · doi:10.1159/000173977 · Cited by 8
Networks and games for precision medicine
Biane, C., Delaplace, F., & Klaudel, H. (2016) · Biosystems · doi:10.1016/j.biosystems.2016.08.006 · Cited by 9
“Schematically, the e ciency of an anticancer drug depends on its ability to impair the proliferation of tumoral cells [21, 35] and, from a Darwinian point-of-view, we can assume that a tumoral cell has an incentive in proliferating [6].”
BackgroundMiller, R. W., Boice, J. D., & Curtis, R. E. (2006) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195149616.003.0048 · Cited by 8
Mechanisms of Stem Cell Ageing
Waterstrat, A., Oakley, E. J., Miller, A. R., Swiderski, C. F., Liang, Y., & Zant, G. E. V. (2007) · Springer eBooks · doi:10.1007/978-3-540-73709-4_6 · Cited by 8
Ortenzio, M. P., Anand, S., Travers, J. B., Maytin, E. V., & Rohan, C. A. (2025) · Photochemistry and Photobiology · doi:10.1111/php.70008 · Cited by 6
“13,22 AK commonly develops on sun-exposed areas, which include the scalp, hands, ears, and face.”
Zhou, Y., Lu, X., Meng, J., Wang, Q.-W., Chen, J.-N., Zhang, Q., Zheng, K. I., Rocha, C. S., Martins, C. B., Yan, F., et al. (2021) · Epigenomics · doi:10.2217/epi-2020-0290 · Cited by 7
Pompei, F., Lee, E., & Wilson, R. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1073-c2 · Cited by 6
Evolutionary biology as a foundation for studying aging and aging-related disease
Ackermann, M., & Pletcher, S. D. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0018 · Cited by 7
Gatza, C. E., Hinkal, G. W., Moore, L. M., Dumble, M. L., & Donehower, L. A. (2005) · Elsevier eBooks · doi:10.1016/b978-012088387-5/50009-1 · Cited by 8
Peto’s “Paradox” and Six Degrees of Cancer Prevalence
Szász, A. (2024) · Cells · doi:10.3390/cells13020197 · Cited by 8
“The p53 induces cellular senescence while it is a tumor suppressor, so the aging and the tumor inhibition may negatively correlate [199,204].”
BackgroundSimilarities in the Age-Specific Incidence of Colon and Testicular Cancers
Soto-Ortiz, L., & Brody, J. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066694 · Cited by 6
Epigenetic regulation of tissue factor inducibility in endothelial cell senescence
Kurz, D. J., Payeli, S., Greutert, H., Schumacher, S. B., Lüscher, T. F., & Tanner, F. C. (2014) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2014.07.002 · Cited by 6
Diet, disease and pigment variation in humans
Khan, R., & Khan, B. S. R. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2010.03.033 · Cited by 7
Aging-associated Non-melanoma Skin Cancer: A Role for the Dermis
Lewis, D. A., Travers, J. B., & Spandau, D. F. (2009) · Springer eBooks · doi:10.1007/978-3-540-89656-2_58 · Cited by 8
“Currently, aging-associated skin cancer has been hypothesized to be a direct result of DNA damage accumulating over time until a threshold is reached overwhelming the tissue resulting in skin cancers [8, 31, 37, 54, 55].”
BackgroundThe population structure of pathogenic bacteria
Dykhuizen, D. E., & Kalia, A. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0014 · Cited by 9
Enhanced Experimental Tumor Metastasis with Age in Senescence-Accelerated Mouse
Shimizu, K., Shimizu, N. K., Asai, T., Tsukada, H., & Oku, N. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.847 · Cited by 6
ANRIL: A Long Noncoding RNA in Age-related Diseases
Wang, R., Yuan, Q. X., Wen, Y., Zhang, Y., Hu, Y., Wang, S., & Yuan, C. (2024) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/0113895575295976240415045602 · Cited by 6
Evo-devo perspectives on cancer
Nedelcu, A. M. (2022) · Essays in Biochemistry · doi:10.1042/ebc20220041 · Cited by 6
Augert, A., & Bernar, D. (2013) · InTech eBooks · doi:10.5772/55519 · Cited by 9
“Indeed, cancer incidence and prevalence increase with age suggesting an important relationship between the two biological processes [118].”
BackgroundInfluentialCheckpoint genes, ageing, and the development of cancer
Wodarz, D. (2004) · Oncogene · doi:10.1038/sj.onc.1207833 · Cited by 5
Identification of two novel human genes, DIPLA1 and DIPAS, expressed in placenta tissue
García, J., & Castrillo, J.-L. (2004) · Gene · doi:10.1016/j.gene.2004.10.004 · Cited by 7
Shortened Telomeres: A Driving Force Behind Leukemia?
Pepper, C. J., & Baird, D. M. (2010) · Future Oncology · doi:10.2217/fon.10.135 · Cited by 6
Chuaire, L. (2006) · Univalle Digital Repository (University of Valle) · Cited by 5
Cancer: evolutionary origins of vulnerability
Greaves, M. F. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0021 · Cited by 7
The evolutionary context of human aging and degenerative disease
Austad, S. N., & Finch, C. E. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0023 · Cited by 6
Resveratrol Inhibitory Effects against a Malignant Tumor
Wcisło, G. (2013) · Polyphenols in Human Health and Disease · doi:10.1016/b978-0-12-398456-2.00096-7 · Cited by 5
The Impact of Lasers and Energy‐Based Devices on Cellular Senescence: A Systematic Review
Kelm, R. C., & Murphrey, M. B. (2025) · Lasers in Surgery and Medicine · doi:10.1002/lsm.70079 · Cited by 6
Unravelling the nexus: Towards a unified model of development, ageing, and cancer
Fontana, A. (2023) · Biosystems · doi:10.1016/j.biosystems.2023.104966 · Cited by 8
Is Akt the Mastermind Behind Age-Related Heart Disease?
Kaminker, P. G. (2004) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2004.8.pe8 · Cited by 4
Oncogenic challenges in stem cells and the link to cancer initiation
Lee, J., Bae, G.-Y., Lee, M.-O., & Cha, H. (2012) · Archives of Pharmacal Research · doi:10.1007/s12272-012-0204-x · Cited by 4
“A tumor surveillance network governed by a variety of tumor suppressors plays an important role in preventing the uncontrolled proliferation of cancer cells (Campisi, 2003).”
BackgroundWilson, P. F., & Bedford, J. S. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5897-7.00001-9 · Cited by 5
Biologia Futura: four questions about ageing and the future of relevant animal models
Kubinyi, E. (2022) · Biologia Futura · doi:10.1007/s42977-022-00135-2 · Cited by 5
“The main mammalian tumoursuppressor mechanisms evolved from ancient mechanisms that regulate embryogenesis/developmental maintenance but now contribute to ageing (i.e. inducing cell death (Campisi 2003).”
BackgroundIs Human Aging a Form of Phenoptosis?
Libertini, G., Corbi, G., Shubernetskaya, O. S., & Ferrara, N. (2022) · Biochemistry (Moscow) · doi:10.1134/s0006297922120033 · Cited by 5
“The only alternative explanation proposed for cell senescence is that this phenomenon, as it would somehow thwart cell proliferation, would constitute a general defense against cancer [112, 113].”
BackgroundArif, K. B., Said, S., Khiro, N. K., Ibrahem, S., & Alghamdi, S. A. A. (2024) · Human Antibodies · doi:10.3233/hab-230011 · Cited by 4
“The first is the enhancement of cancer driving mutations due to an impaired DNA repair system [29] and the second is some enzymes with inflammatory cytokines and growth factors secreted by senescent cells which may causes a damage in the tissue structures [30].”
Mining Cellular Senescence for Drug Targets
Bilsland, A. E., & Keith, W. N. (2009) · Springer eBooks · doi:10.1007/978-1-4419-1075-2_10 · Cited by 3
“It is generally believed that senescence provides a vital tumor suppressor function in this context, limiting the growth of aged or damaged cells (Campisi 2003).”
BackgroundCardiac Regeneration and Aging
Leri, A., Kajstura, J., & Anversa, P. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-381332-9.00045-1 · Cited by 3
Moon, E., Kim, H. S., & Im, Y.-S. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.02.020 · Cited by 3
Senescent human keratinocytes suppress colony formation of HeLa cells
Bacon, P. E., Bodner, B. K., & Nickoloff, B. J. (2005) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2004.12.023 · Cited by 3
Wang, X. (2012) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2012.01.001 · Cited by 5
Perspectives on human health and disease from evolutionary and behavioral ecology
Strassmann, B. I., & Mace, R. H. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0009 · Cited by 4
Aging-Associated Nonmelanoma Skin Cancer: A Role for the Dermis
Lewis, D. A., Krbanjevic, A., Travers, J. B., & Spandau, D. F. (2015) · Springer eBooks · doi:10.1007/978-3-642-27814-3_58-2 · Cited by 3
Reuben, D. B., & Naeim, A. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.09.960 · Cited by 3
Beáta, V. (2016) · Cited by 3
Nazki, F. H., & Bracken, C. P. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05832-4 · Cited by 5
“In contrast to adult cancers linked to aging [6–8], NB emerges as a developmental disorder originating from neural crest cells (NCCs) - a multipotent, stem-like population that ultimately gives rise to a diverse array of tissues at distal sites [9, 10].”
Evolutionary genetics of ageing
Dönertaş, H. M., & Partridge, L. (2026) · Nature Reviews Genetics · doi:10.1038/s41576-026-00959-x · Cited by 3
“This dual role, protective in youth, pathogenic in old age, reflects antagonistic pleiotropy 183 .”
Aoshiba, K., Tsuji, T., Itoh, M., Yamaguchi, K., & Nakamura, H. (2015) · Respiration · doi:10.1159/000369861 · Cited by 4
21: Cancer and ageing: Rival demons?
Campisi, J. (2014) · European Journal of Cancer · doi:10.1016/s0959-8049(14)50021-4 · Cited by 2
Self-citationChen, L., Wang, Y., Wang, Z., & Wang, H. (2023) · Journal of Statistical Physics · doi:10.1007/s10955-023-03095-6 · Cited by 2
Obtaining Longevity Footprints in DNA Methylation Data Using Different Machine Learning Approaches
Kalyakulina, A., Yusipov, I., & Ivanchenko, M. (2023) · Healthy ageing and longevity · doi:10.1007/978-3-031-35176-1_4 · Cited by 2
PARG Protein Regulation Roles in Drosophila Longevity Control
Bordet, G., & Tulin, A. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116189 · Cited by 2
“This decline manifests as a heightened susceptibility to mortality and a spectrum of age-related diseases, encompassing specific cancers [1,2] and cardiovascular issues [3], but also neurodegenerative conditions like macular degeneration [4], Alzheimer’s disease [5], or osteoporosis [6].”
BackgroundUnveiling CDKN2B-AS1: The functional long noncoding RNA driving age-related diseases
Chen, H., Huan, Q., Wang, Z., Cheng, W., Zhai, J., & Wu, G. (2025) · Gene Reports · doi:10.1016/j.genrep.2025.102247 · Cited by 5
Pain in the elderly with cancer
Yayla, E. M. (2015) · Turkish Journal of Oncology · doi:10.5505/tjoncol.2015.994 · Cited by 2
Cytogenetic aberrations in primary cell cultures of the ovarian surface epithelium.
Chuaire, L., Rondón-Lagos, S., Ramírez-Corredor, A., Ibáñez‐Pinilla, M., & Ramírez-Clavijo, S. R. (2010) · PubMed · Cited by 2
The Stem Cell Hypothesis of Aging
Meiliana, A., & Wijaya, A. (2010) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v2i1.108 · Cited by 2
Health consequences of ecogenetic variation
Bamshad, M. J., & Motulsky, A. G. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0004 · Cited by 2
Immunologie et cancer. 1re partie: r�ponse immunitaire antitumorale
Calmels, B. (2004) · ONCOLOGIE · doi:10.1007/s10269-004-0118-4 · Cited by 2
Molecular and cellular parameters of ageing: an overview
Thukral, H., Soin, S., Rani, R., & Sarkar, A. (2016) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 3
Phylogeny of age-related fitness decline in the wild and of related phenomena
Libertini, G. (2011) · Cited by 2
Pourquoi n’avoir que deux copies du gèneP53?
Weill, J. (2017) · médecine/sciences · doi:10.1051/medsci/20173311018 · Cited by 2
Metadata
- Authors
- Campisi, J.
- Affiliations
- Lawrence Berkeley National Laboratory (US)
- Corresponding author
- Campisi, Judith
- ORCID
- Campisi, Judith
- Venue
- Nature Reviews Cancer
- Published
- 2003-05
- Volume
- 3
- Issue
- 5
- Pages
- 339-349
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2096846805
- Cited by
- 512
- References
- 158
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 9 · 2023: 12 · 2022: 14 · 2021: 15 · 2020: 10 · 2019: 10 · 2018: 18 · 2017: 19 · 2016: 16 · 2015: 23 · 2014: 20 · 2013: 19 · 2012: 23
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- cancer, aging, tumor suppressor pathways, somatic maintenance, embryonic development
- MeSH terms
- Aging, DNA Repair, Humans, Longevity, Neoplasms, Tumor Suppressor Protein p53, Retinoblastoma Protein, Cellular Senescence, Apoptosis, Genomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.